Human Serum Albumin Aggregation and its Modulation Using Nanoparticles: A Review.

Area of Science:

• Biochemistry
• Nanotechnology
• Neuroscience

Background:

• Amyloid fibrils are implicated in neurodegenerative diseases like Alzheimer's.
• Inhibiting protein aggregation is a key therapeutic strategy.
• Human Serum Albumin (HSA) serves as a model for studying amyloid formation.

Purpose of the Study:

• To review the effects of nanoparticles on HSA aggregation.
• To elucidate the mechanisms of nanoparticle-mediated amyloid modulation.
• To identify potential therapeutic strategies against amyloidosis.

Main Methods:

• Literature review of studies on nanoparticles and HSA aggregation.
• Analysis of nanoparticle properties influencing amyloid formation.
• Exploration of mechanisms of action for nanoparticle-based inhibition.

Main Results:

• Nanoparticles exhibit unique properties beneficial for inhibiting amyloid aggregation.
• Various nanoparticles demonstrate efficacy in modulating HSA conformational changes.
• Mechanistic insights into nanoparticle-amyloid interactions are provided.

Conclusions:

• Nanoparticles represent a promising therapeutic avenue for amyloidosis.
• Understanding nanoparticle-HSA interactions is crucial for developing effective treatments.
• Further research into nanoparticle-mediated amyloid modulation is warranted.